NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in individuals with motor impairment, today announced the ...

In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

A new protocol will allow users implanted with Synchron’s brain-computer interface (BCI) device to control iPhone, iPad and Apple Vision Pro directly with their thoughts without the need for physical ...

Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

A new brain implant now lets people control Apple devices, such as iPads, iPhones and the Vision Pro, using only their thoughts. Synchron, an endovascular brain-computer interface (BCI) company based ...

Apple has worked on a new standard with Synchron on a brain-computer interface that, among other things, aids folks with disabilities, according to the Wall Street Journal. Synchron has made a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Interim results from the COMMAND study evaluating the ...

Neurotech company Synchron has been making massive strides over the past couple of years. It's just announced that a trial participant has used its brain-computer interface (BCI) to turn on the lights ...

Synchron has developed a minimally invasive brain-computer interface capable of controlling devices like Apple Vision Pro, and it has reached the one-year milestone without serious adverse effects to ...

New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

BUFFALO, N.Y. – Results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis will be presented Sept. 30 at the Congress of ...